Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata

Archives of Gynecology and Obstetrics

Volumn 258, Issue 1, 1996, Pages 35-41

  Cardamakis, E K ^a,d   Kotoulas, I G B ^b   Dimopoulos, D P ^a   Stathopoulos, E N ^c   Michopoulos, J T ^b   Tzingounis, V A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b E Venizelou Hospital   (Greece)

^c ATHENS NAVAL HOSPITAL   (Greece)

^d NONE   (Greece)

Author keywords

Interferon alfa 2a; Isotretinoin; Recurrent condylomata accuminata

Indexed keywords

ANTI ACNE AGENT; ISOTRETINOIN; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ALOPECIA; ARTICLE; CHEILITIS; CHILL; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY EYE; DRY SKIN; FATIGUE; FEMALE; FEVER; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALAISE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; INTERFERON ALFA-2A; ISOTRETINOIN; RECURRENCE;

EID: 0030022634     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040050098     Document Type: Article

References (39)

1. Alberts DS, Coulthard SW, Meyskens FL (1986) Regression of aggressive laryngeal papillomatosis with 13-cis-retinoic acid (Accutane). J Biol Response Med 5:124-128
2. Bertram JS, Mariner JE (1984) Retinoids inhibitory of neoplastic transformations in vitro: mechanistic studies. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger
3. Borden EC, Ball LA (1981) Interferons: biochemical, cell growth inhibitory and immunological effects. Prog Hematol 12:299-339
4. Boutwell RK, Verma HK, Loprinzi CM, Carbone PP (1984) Retinoids as inhibitors of tumor promotion. In: Saurat JH (ed) Retinoid Symposium, Basel: Karger
5. Boyle J, Dick DC, Mackie RM (1983) Treatment of extensive virus warts with etretinate (Tegison) in a patient with sarcoidosis. Clin Exp Dermatol 8:33-36
6. Cardamakis E, Deligeorouglou E, Hassan E, Creatsas G, Aravantinos D (1991a) Treatment of recurrent condylomata accuminata with etetrinate (Tigason, Roche): preliminary report in 13 adolescents. In: Advances on pediatric and adolescent gynecology, Athens, December 13-14. Book of Abstract, p 2
7. 2 (vaporization, cone) and 5-fluorouracil 5% (5-FU). EJC (Abstract) 5 [Suppl. 2]:219
8. Claudy AL, Touraine GL, Mitanne D (1982) Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Arch Dermatol Res 274:213-219
9. Claudy AL, Rouchouse B (1984) Treatment of cutaneous T-cells lymphomas with synthetic retinoids. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger
10. Connor MJ, Lowe NJ (1984) Retinoid stimulation of epidermal cell growth in vivo. In: Saurat JH (ed) Retinoid symposium. Basel: Karger
11. Deligeoroglou E, Cardamakis E, Hassan E, Creatsas G, Aravantinos D (1992) Comparative study of systemic interferon alfa-2a plus etetrinate vs etetrinate in the treatment of recurrent condylomata accuminata: preliminary report in 33 adolescents. Adolesc Pediatr Gynecol (Abstract) 5:125
12. Dicken Ch, Connolly SM (1982) Systemic retinoids in dermatology. Mayo Clinic Proc 57:51-53
13. Douglas Jr JM, Rogers M, Jutson FN (1986) The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant alpha-2a interteron. J Infect Dis 154:331-334
14. Elias PN, Williams ML (1984) Retinoid effect on epidermal structure, differentiation and permeability. In: Saurat JH (ed) Retinoid symposium. Basel: Karger
15. Ferenczy A, Mitao M, Nagai N, Silverstein SJ, Crum CP (1985) Latent papillomavirus and recurring genital warts. N Engl J Med 313:784-788
16. Gross G, Pfister H, Hagedorn M, Stahn R (1983) Effect of oral aromatic retinoid (Ro 10-9359) on human papillomavirus-2-induced common warts. Dermatologica 166:48-53
17. Jablonska S, Obalek S, Wolska H, Jazzabek-Chozzelska M (1981) Ro 10-9359 in epidermodysplasia verruciformis. Preliminary report. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MK, Schuppli R (eds) Retinoids advances in basic research and therapy. Berlin: Springer, p 401
18. Lippman S, Kavanagh J, Paredes-Espinoza M, et al. (1992) 13-cis-Retinoic acid plus interferon-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84:241-245
19. Lotan R (1984) Mechanism of inhibition of tumor cell proliferation by retinoids: studies with cultured melanoma cells. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger
20. Lutzner MA (1981) Oral retinoid treatment of human papillomavirus type 5-induced epidermodysplasia verruciformis. N Engl J Med 302:1091-1093
21. Lutzner MA (1983) The human papillomaviruses. Arch Dermatol 119:631-635
22. MacGuire J, Fedarko N, Joannsenn E (1982) The influence of retinoids on cultivated human keratinocytes. J Am Acad Dermatol [Suppl.] 6:630-639
23. Meyskens FL (1982) Studies of retinoids in the prevention and treatment of cancer. J Am Acad Dermatol [Suppl.] 6:824-827
24. Molin L, Thomsen K, Volden G, Wantzin GL, Hellbe L (1984) 13-cis retinoid acid-effective treatment in mycosis fungoides. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger
25. Moon RC, MacCormick DL (1982) Inhibition of chemical carcinogenesis by retinoids. J Am Acad Dermatol [Suppl.] 6:809-814
26. Munkvad M, Geuner J, Staberg B, Kongsholm H (1983) Locally injected bleomycin in the treatment of warts. Dermatologica 167:86-89
27. Olsen E, Kelly F, Vollmer R, Buddin D, Weck P (1989) Comparative study of systemic interferon alfa-2a and isotretinoin in the treatment of resistant condylomata accuminata. J Am Acad Dermatol 20:1023-1030
28. Peck GL, Gross EG, Butky D, DiGiovanna JJ (1982) Chemoprevention of basal cell carcinoma with isotretinoin. J Am Acad Dermatol [Suppl.] 6:815-823
29. Peck GL (1984) Therapy and prevention of skin cancer. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger
30. Pigatto PD, Bersani L, Nobile G, De Luca A, De Blasio A, Altanare GF (1984) Effect of retinoid administration on natural killer cell activity. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger
31. Pittsley RA, Yoder FW (1983) Retinoid hyperostosis. Skeletal toxicity associated with long-term administration of 13-cis-retinoic acid for refractory icthyosis. N Engl J Med 308:1012-1014
32. Pochi PE (1982) Oral retinoids in dermatology. Arch Dermatol 118:57-61
33. Ringenberg QS, Anderson PC (1986) Interferons in the treatment of skin disease. Int J Dermatol 25:273-279
34. Rusciani L. Larussa FM, De Simone C, De Sole P, Lippa S, Serri F (1984) Study of the biological function of neutrophils in patients undergoing therapy with the aromatic retinoid Ro 10-9359. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger
35. Shapiro PE, Edelsonn RL (1984) Retinoids and immunology. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger
36. Sillevis-Smitt JH, De Mari F (1984) A serious side effect of etetrinate (Tigason). Clin Exp Dermatol 9:554-556
37. Sporn MB (1981) Retinoids: new developments in their mechanism of action as related to control proliferative diseases. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch. Polano MK, Schuppli R (eds) Retinoids, advances in basic research and therapy. Berlin: Springer, p 73
38. Verret JL, Schnitzler L, Avenel M, Smulevici A (1984) Etetrinate and skin cancer prevention. A 6-year follow-up study. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger
39. Ympa SH, Lichti U (1984) Retinoids and carcinogenesis. In: Saurat JH (ed) Retinoid Symposium. Basel: Karger